CDTX vs PHM · rev $1.3M vs P/E 7.7, rev $17.95B
Cidara Therapeutics Inc (CDTX) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
CDTX currently screens at market cap $6.96B. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the CDTX and PHM stock pages for the full models.
Not investment advice.